Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Douglas F. Easton, Paul D.P. Pharoah, Antonis C. Antoniou et al. · New England Journal of Medicine · 2015 · 937 citations · Full text

Life Sciences, Genetics, Oncology +17

<i>TP53</i>Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

Liacine Bouaoun, Dmitriy Sonkin, Maude Ardin et al. · Human Mutation · 2016 · 746 citations

Medicine, Genetics, Molecular Genetics +17

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

Fergus J. Couch, Hermela Shimelis, Chunling Hu et al. · JAMA Oncology · 2017 · 627 citations · Full text

Life Sciences, Genetics, Oncology +17

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study

Anita Villani, Ari Shore, Jonathan D. Wasserman et al. · The Lancet Oncology · 2016 · 526 citations

Life Sciences, Genetics, Molecular Genetics +12

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

Susan J. Ramus, Honglin Song, Ed Dicks et al. · JNCI Journal of the National Cancer Institute · 2015 · 442 citations · Full text

Life Sciences, Genetics, Oncology +16